U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
136681136681Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With CancerActive, not recruitingNo Results AvailableProstate Cancer|Elevated Prostate Specific Antigen (PSA)Other: serum specimens obtained will be utilized for proteomic profiling comprising MALDI-TOF MS, and serum biomarker assays.https://ClinicalTrials.gov/show/NCT00773773
136682136682MOR and COMT SNP Polymorphism and PainRecruitingNo Results AvailablePain ReliefOther: SNP genotypinghttps://ClinicalTrials.gov/show/NCT00773760
136683136683Study of Vorinostat (MK-0683) an HDAC Inhibitor, or Placebo in Combination With Bortezomib in Patients With Multiple Myeloma (MK-0683-088 AMN)CompletedNo Results AvailableMultiple MyelomaDrug: vorinostat|Drug: bortezomib|Drug: placebo to vorinostathttps://ClinicalTrials.gov/show/NCT00773747
136684136684Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)CompletedHas ResultsPsoriasis|Plaque-type PsoriasisDrug: Apremilast 10mg|Drug: Apremilast 20mg|Drug: Apremilast 30 mg|Drug: Placebo|Drug: Apremilast 30mg|Drug: Apremilast 20mghttps://ClinicalTrials.gov/show/NCT00773734
136685136685[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT00773721
136686136686Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed ProductCompletedNo Results AvailableHIV InfectionsDrug: raltegravirhttps://ClinicalTrials.gov/show/NCT00773708
136687136687A Study of Avastin (Bevacizumab) in Combination With Neoadjuvant Treatment Regimens in Patients With Primary HER2 Negative Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: Placebo|Drug: Standard chemotherapy or endocrine therapy|Drug: bevacizumab [Avastin]https://ClinicalTrials.gov/show/NCT00773695
136688136688Efficacy and Tolerability of Mud Packs Therapy in Osteoarthritis of the HandCompletedNo Results AvailableOsteoarthritisOther: local mud-pack therapy and balneotherapyhttps://ClinicalTrials.gov/show/NCT00773682
136689136689Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007CompletedNo Results AvailableBreast Cancerhttps://ClinicalTrials.gov/show/NCT00773669
136690136690Patients Overexposed for a Prostate AdenocarcinomaCompletedNo Results AvailableProstate AdenocarcinomaOther: Whole blood samplehttps://ClinicalTrials.gov/show/NCT00773656
136691136691Osteogenic Profiling of Tissue From Children With CraniosynostosisRecruitingNo Results AvailableCraniosynostosisOther: biopsyhttps://ClinicalTrials.gov/show/NCT00773643
136692136692A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed ConditionsCompletedNo Results AvailableIntermittent ClaudicationDrug: Cilostazolhttps://ClinicalTrials.gov/show/NCT00773630
136693136693Testing an Alternative Therapy for Bulimia NervosaCompletedNo Results AvailableEating DisordersBehavioral: ICAT|Behavioral: CBThttps://ClinicalTrials.gov/show/NCT00773617
136694136694Deep Brain Stimulation in Patients With DystoniaCompletedNo Results AvailableDystoniaDevice: Medtronic implantable deep brain stimulation (DBS) systemhttps://ClinicalTrials.gov/show/NCT00773604
136695136695Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing DisordersWithdrawnNo Results AvailableSleep-Disordered BreathingDrug: NT 201, a Botulinum neurotoxin type A, free of complexing proteinshttps://ClinicalTrials.gov/show/NCT00773591
136696136696Exhaled Nitric Oxide and Nasal Lavage FluidCompletedNo Results AvailableAsthmaDevice: Measurement of exhaled nitric oxide (eNO)|Device: Measurement of biomarkers of nasal inflammationhttps://ClinicalTrials.gov/show/NCT00773578
136697136697Identification of Novel Targets for Regulation of Adipose Tissue MassCompletedNo Results AvailableObesityDietary Supplement: Optifasthttps://ClinicalTrials.gov/show/NCT00773565
136698136698Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive BladderNot yet recruitingNo Results AvailableUrinary Urge|Urge Incontinence|Overactive BladderDrug: solifenacin succinate|Drug: placebohttps://ClinicalTrials.gov/show/NCT00773552
136699136699A Prospective Randomized Study Comparing Radiofrequency Energy With CryoenergyRecruitingNo Results AvailableAtrial Fibrillation AblationProcedure: PVI using an open irrigated tip catheter|Procedure: PVI using a closed irrigated tip catheter|Procedure: PVI using a cryoballoonhttps://ClinicalTrials.gov/show/NCT00773539
136700136700A Dose-Escalation Study of RO5126766 in Patients With Advanced Solid Tumors.CompletedNo Results AvailableNeoplasmsDrug: RO5126766https://ClinicalTrials.gov/show/NCT00773526
136701136701A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs.Active, not recruitingNo Results AvailableAnemiaDrug: ESAs (darbepoetin alfa, epoetin alfa or epoetin beta)|Drug: methoxy polyethylene glycol-epoetin beta [Mircera]|Drug: methoxy polyethylene glycol-epoetin beta [Mircera]https://ClinicalTrials.gov/show/NCT00773513
136702136702Impact of Vendor Systems on Ambulatory Medication SafetyCompletedNo Results AvailableMedication ErrorsOther: Electronic prescribinghttps://ClinicalTrials.gov/show/NCT00773500
136703136703Influence of Diesel Exhaust Particles (DEP) With and Without Organic Compounds on the Allergic Inflammation in Asthmatic SubjectsCompletedNo Results AvailableAsthmaOther: Bonchoscopyhttps://ClinicalTrials.gov/show/NCT00773487
136704136704Lonafarnib in Metastatic Breast CancerTerminatedNo Results AvailableMetastatic Breast CancerDrug: Lonafarnibhttps://ClinicalTrials.gov/show/NCT00773474
136705136705A Study of Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis.CompletedNo Results AvailableRheumatoid ArthritisDrug: tocilizumab [RoActemra/Actemra]|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00773461
136706136706Screening for Occult Malignancy in Patients With Idiopathic Venous ThromboembolismCompletedNo Results AvailableVenous Thromboembolism|Deep Vein Thrombosis|Pulmonary EmbolismDevice: Comprehensive computed tomography of the abdomen/pelvis|Other: Limited Malignancy Screeninghttps://ClinicalTrials.gov/show/NCT00773448
136707136707Effects of Echinacea in ChildrenWithdrawnNo Results AvailableUpper Respiratory InfectionsBiological: Echinacea purpurea 100 mg/ml in liquid formulation|Other: placebohttps://ClinicalTrials.gov/show/NCT00773435
136708136708The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking LapseActive, not recruitingNo Results AvailableSmokingDrug: naltrexone|Drug: varenicline|Drug: placebohttps://ClinicalTrials.gov/show/NCT00773422
136709136709Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA)CompletedNo Results AvailableRenal Insufficiencyhttps://ClinicalTrials.gov/show/NCT00773409
136710136710[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT00773396

* Görseller ve İçerik tekif hakkına sahip olabilir